Dementia trials recruiting in North Carolina

All Dementia trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
  NCT07602582 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · North Carolina: Monroe
• ADRC Clinical Cohort (Alzheimer's Disease)
  NCT06703541 · Phase: Not specified · Ages: 25 Years to 80 Years · Sex: All (male and female) · North Carolina: Durham
• Connect-Home: Alzheimer's Disease and Related Dementias
  NCT06840587 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill
• Improving PCP Advance Care Planning for People With ADRD
  NCT06565169 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · North Carolina: Chapel Hill